Jens Benn Sørensen

Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis.

Jens Benn Sørensen, Heine H. Hansen, M Hansen et al. · Journal of Clinical Oncology · 1988 · 343 citations

Medicine, Oncology, Chemotherapy +13

Risk factors and prevention of cardiotoxicity induced by 5-fluorouracil or capecitabine

Søren Astrup Jensen, Jens Benn Sørensen · Cancer Chemotherapy and Pharmacology · 2006 · 232 citations

Medicine, Pharmacology, Pharmacotherapy +12

Acute tumor lysis syndrome in solid tumors—a case report and review of the literature

Jens Benn Sørensen · Cancer Chemotherapy and Pharmacology · 2003 · 201 citations

Medicine, Hematology, Oncology +7

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

Giorgio V. Scagliotti, Rabab Gaafar, Anna K. Nowak et al. · The Lancet Respiratory Medicine · 2019 · 167 citations

Medicine, Oncology, Pharmacology +10

Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial

Federica Grosso, Nicola Steele, Silvia Novello et al. · Journal of Clinical Oncology · 2017 · 140 citations · Full text

Medicine, Oncology, Pharmacotherapy +14